CBC
A lesser-known major cannabinoid
Cannabinoid
What is CBC?
CBC stands for Cannabichromene. Though lesser studied, it has shown great therapeutic and analgesic potential when combined with CBD and THC.
How CBC works
Going through a few studies linked at the bottom of this tab lead me to a few tidbits.
First and foremost, CBC does not interact with the CB1 receptor, however it is a proven CB2 receptor compound. It acts as a surface inhibitor to CB2 receptors, lowering the reactivity and uptake in CB2 binding compounds.
Now we know CB2 receptors are primarily activated when inflammation is present.
How this applies to us
As best I can tell (and reading another study linked below), since research is still younger with CBC, CBC is a potential down-regulator of inflammatory responses in humans. When applied to diseases and conditions with chronic pain due to overreaction of our immune response — conditions where the problem stems from someone's immune system overreacting to a body's pain and inflammation response — Lupus, rheumatoid arthritis (RA), and psoriasis, to name a few, are potentials.
Non-psychoactive medicine
The other benefit to CBC is it contains basically no psychoactivity. Since cannabis has begun to grow and expand in the mainstream, we as users must understand the absolute necessity for non-psychoactive treatments for patients. A 'high' is not necessary for many conditions and especially in a therapeutic environment. There are a large number of people who do not tolerate the effects of THC well and need routes and pathways to achieve the help they need without displacing their own comfort.
Closing notes
At this time this is about the limit of my knowledge on CBC.
Conditions that cite this compound
These condition guides point here — they cover the same compound from the patient side.